On the Putative Co-transport of Drugs by Multidrug Resistance Proteins.
From: Center of Biomedical Genetics, Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. p.borst@nki.nl
FEBS letters
- Publish Date: Feb 2006
- ISSN: 0014-5793
- Volume: 580
- Issue: 4
- Pages: 1085-93
- Medium: Print
- Language: English
- Citation (JAMA): Borst P, Zelcer N, van de Wetering K, et al. On the Putative Co-transport of Drugs by Multidrug Resistance Proteins.. FEBS Lett. Feb 2006;580:1085-93
Abstract
Experiments with multidrug resistance-associated protein 1 (MRP1) showed 10-years ago that transport of vincristine (VCR) by MRP1 could be stimulated by GSH, and transport of GSH by VCR. Since then many examples of stimulated transport have been reported for MRP1, 2, 3, 4 and 8. We discuss here three models to explain stimulated transport. We favour a model in which a large promiscuous binding site can bind more than one ligand, allowing cooperative/competitive interactions between ligands within the binding site. We conclude that there is no unambiguous proof for co-transport of two different ligands by MRPs, but that cross-stimulated transport can explain the published data.
Mesh Headings (Keywords): Animals, Binding Sites, Biological Transport, Humans, Multidrug Resistance-Associated Proteins, Pharmaceutical Preparations
Check for Full Text / PubMed Unique Identifier (PMID): 16386247
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.